Skip to main content

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Research lines

Psychiatric Genetics

IP: Marta Ribases Haro

Projects

Más allá del riesgo genético para el TDAH: contribución genética a la resiliencia en una muestra clínica

IP: Marta Ribases Haro
Collaborators: Montserrat Corrales De la Cruz, Judit Cabana Dominguez, Laura Gisbert Gustemps, Gemma Español Martín, Vanesa Richarte Fernández, Christian Fadeuilhe Grau
Funding agency: Instituto de Salud Carlos III
Funding: 131250
Reference: PI23/00404
Duration: 01/01/2024 - 31/12/2026

Grup consolidat

IP: José Antonio Ramos Quiroga
Collaborators: Pilar Lusilla Palacios, Natalia Calvo Piñero, Amanda Rodríguez Urrutia, Montserrat Corrales De la Cruz, Judit Cabana Dominguez, Marc Ferrer Vinardell, Gemma Nieva Rifa, Mª Dolores Braquehais Conesa, Lara Grau Lopez, Constanza Daigre Blanco, Marta Ribases Haro, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Mireia Forner Puntonet, Christian Fadeuilhe Grau, Francisco Collazos Sanchez, Silvia Alemany Sierra, Silvia Amoretti Guadall, Gara Arteaga Henriquez, Natalia Llonga Tejedor, Maria Soler Artigas, Jorge Lugo Marin
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00840
Duration: 01/01/2022 - 30/06/2025

Impact of Neurodevelopmental Disorders on School Performance: genes and environment (INSchool)

IP: Marta Ribases Haro
Collaborators: Gemma Español Martín, Judit Cabana Dominguez, José Antonio Ramos Quiroga, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Silvia Alemany Sierra, Natalia Llonga Tejedor, Maria Soler Artigas
Funding agency: Fundació La Marató de TV3
Funding: 199187.5
Reference: 202228-30-31
Duration: 20/04/2023 - 19/04/2026

DynAMoND - Dinámica de la modulación afectiva en los trastornos del neurodesarrollo

IP: José Antonio Ramos Quiroga
Collaborators: Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, Marta Ribases Haro, Vanesa Richarte Fernández, Christian Fadeuilhe Grau
Funding agency: Instituto de Salud Carlos III
Funding: 174845
Reference: AC21_2/00048
Duration: 01/01/2022 - 31/12/2024

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Deborah Pareto Onghena

Deborah Pareto Onghena

Main researcher
Neuroradiology
Read more
Mª Dolores Braquehais Conesa

Mª Dolores Braquehais Conesa

Main researcher
Psychiatry, Mental Health and Addictions
Read more
Lucas Rivera Sánchez

Lucas Rivera Sánchez

Read more
Clara Carnicer Cáceres

Clara Carnicer Cáceres

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.